Insulin glargine and lixisenatide and Rituxan Hycela
Determining the interaction of Insulin glargine and lixisenatide and Rituxan Hycela and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Rituximab
- Insulin glargine and lixisenatide-Rituximab and Hyaluronidase
- Insulin glargine and lixisenatide-Rituximab and hyaluronidase human, recombinant Subcutaneous
- Insulin glargine and lixisenatide-Rituximab Intravenous
- Insulin glargine and lixisenatide-Riva-Amoxicillin
- Insulin glargine and lixisenatide-Rivaroxaban
- Rituxan Hycela-Insulin glargine and lixisenatide Subcutaneous
- Rituxan Hycela-Insulin glargine, recombinant Subcutaneous
- Rituxan Hycela-Insulin glulisine
- Rituxan Hycela-Insulin Glulisine (Cartridges and Pens)
- Rituxan Hycela-Insulin Glulisine (Vials)
- Rituxan Hycela-Insulin glulisine Subcutaneous